Abstract
Over the past few years, there has been an increasing interest in drugs having a tranquillizing or ataractic effect on the central nervous system. Pharmaceutical houses, both here and on the other side of the Atlantic, have vied with one another to be the first to introduce the perfect tranquillizer, providing relief from tension and anxiety with no unpleasant or dangerous side-effects or tendency to addiction, and at the same time if possible to effect an improvement in the management of, if not the cure of, the psychoses.
Publisher
Royal College of Psychiatrists
Reference6 articles.
1. Lim R. K. S. , Pindell M. H. , Glass H. G. , and Rink K. G. , New York Academy of Science, 1956, 9 March.
2. Rauwolfia Alkaloids and Reserpine in the Treatment of the Chronic Psychotic Patient
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Chlorpromazine versus placebo for schizophrenia;Cochrane Database of Systematic Reviews;2014-01-06
2. Chlorpromazine versus placebo for schizophrenia;Cochrane Database of Systematic Reviews;2007-04-18
3. Chlorpromazine versus placebo for schizophrenia;Cochrane Database of Systematic Reviews;2003-04-22
4. Meprobamate-like Agents Bibliographies;Psychopharmacological Agents;1967